Division of Oncology 1 (DO1)
The Division of Oncology 1 (DO1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for breast, gynecologic, and genitourinary cancers, as well as supportive care (non-hematologic) products.
Mailing Address
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology 1 (DO1)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2330
Fax: (301) 796-9845
